Education
About Us
Working with TipRanks
Follow Us
Nova Eye Medical (AU:EYE)
ASX:EYE
EYE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.09 - AU$0.30
Previous CloseN/A
Volume155.74K
Average Volume (3M)382.21K
Market Cap
$35.52M
Enterprise ValueAU$35.44M
Total Cash (Recent Filing)$2.26M
Total Debt (Recent Filing)AU$3.38M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Aug 27, 2025EPS Estimate
>-0.01Last Dividend Ex-Date
Jul 21, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding284,146,000
10 Day Avg. Volume536,452
30 Day Avg. Volume382,215
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.78
Price to Sales (P/S)0.00
P/FCF Ratio-5.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nova Eye Medical News
PremiumCompany Announcements
Nova Eye Medical Hosts Investor Webinar to Discuss Ophthalmic Innovations
PremiumCompany Announcements
Nova Eye Medical Achieves Record Revenues in FY25
PremiumCompany Announcements
Nova Eye Medical to Host Investor Webinar on FY25 Sales Results
PremiumCompany Announcements
Nova Eye Medical Announces Cessation of Performance Rights
PremiumCompany Announcements
Nova Eye Medical Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Nova Eye Medical Announces Investor Webinar Amid Market Growth
PremiumCompany Announcements
Nova Eye Medical Issues Shares to Consultant, Bolstering Market PositionPremiumCompany Announcements
Nova Eye Medical to Quote New Securities on ASXOptions Prices
Currently, No data available
---
Ownership Overview
4.77% Insiders
―
Mutual Funds
― Other Institutional Investors
95.23% Public Companies and
Individual Investors
EYE FAQ
What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest share price was AU$0.09 and its highest was AU$0.29 in the past 12 months.
What is Nova Eye Medical’s market cap?
Nova Eye Medical’s market cap is $35.52M.
When is Nova Eye Medical’s upcoming earnings report date?
Nova Eye Medical’s upcoming earnings report date is Aug 27, 2025 which is in 50 days.
How were Nova Eye Medical’s earnings last quarter?
Nova Eye Medical released its earnings results on Feb 25, 2025. The company reported -AU$0.024 earnings per share for the quarter, missing the consensus estimate of -AU$0.007 by -AU$0.017.
Is Nova Eye Medical overvalued?
According to Wall Street analysts Nova Eye Medical’s price is currently Overvalued.
Does Nova Eye Medical pay dividends?
Nova Eye Medical pays a Notavailable dividend of AU$0.414 which represents an annual dividend yield of N/A. See more information on Nova Eye Medical dividends here
What is Nova Eye Medical’s EPS estimate?
Nova Eye Medical’s EPS estimate is >-0.01.
How many shares outstanding does Nova Eye Medical have?
Nova Eye Medical has 284,146,000 shares outstanding.
What happened to Nova Eye Medical’s price movement after its last earnings report?
Nova Eye Medical reported an EPS of -AU$0.024 in its last earnings report, missing expectations of -AU$0.007. Following the earnings report the stock price went down -4.167%.
Which hedge fund is a major shareholder of Nova Eye Medical?
Currently, no hedge funds are holding shares in AU:EYE
Nova Eye Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:EYE Sentiment 93%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-50.50%
Trailing 12-Months
Asset Growth
-2.47%
Trailing 12-Months
Company Description
Nova Eye Medical
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.
Technical Analysis
Compumedics Limited
―
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Control Bionics Ltd.
―